Ardent Health Partners (NYSE:ARDT) Receives Overweight Rating from Stephens

Stephens restated their overweight rating on shares of Ardent Health Partners (NYSE:ARDT) in a report released on Wednesday,Benzinga reports. They currently have a $22.00 price target on the stock.

A number of other research firms also recently commented on ARDT. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $20.00 price objective on shares of Ardent Health Partners in a report on Tuesday, December 17th. Truist Financial cut their price target on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a report on Monday, January 6th. Morgan Stanley lowered their price objective on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 21st. Finally, Royal Bank of Canada cut their target price on Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating for the company in a research note on Tuesday, March 4th. Two equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, Ardent Health Partners presently has an average rating of “Buy” and a consensus target price of $21.18.

Ardent Health Partners Trading Down 0.2 %

NYSE ARDT opened at $13.09 on Wednesday. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. Ardent Health Partners has a 1-year low of $12.87 and a 1-year high of $20.72. The stock’s 50 day simple moving average is $14.44 and its 200-day simple moving average is $16.30.

Ardent Health Partners (NYSE:ARDT) last announced its earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.31. The business had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.48 billion. Research analysts anticipate that Ardent Health Partners will post 1.23 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of ARDT. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Ardent Health Partners during the fourth quarter worth $27,000. US Bancorp DE purchased a new position in Ardent Health Partners during the 4th quarter valued at about $31,000. R Squared Ltd acquired a new position in Ardent Health Partners in the 4th quarter valued at about $37,000. BNP Paribas Financial Markets purchased a new stake in Ardent Health Partners during the third quarter worth about $42,000. Finally, New York State Common Retirement Fund acquired a new stake in shares of Ardent Health Partners during the fourth quarter worth about $48,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.